Refine your search
7 results found
Slaughter and May | United Kingdom | 15 Mar 2023
Oxford University's IP policy put under microscope: implications for life sciences companies
As part of a novel defence to a claim for unpaid royalties relating to the use of IP rights in a specialised microscope, the High Court recently considered the effect of consumer protection law on a university's IP policy. This decision will be of particular importance for those in the life sciences sector that are in the habit of collaborating, or otherwise dealing, with universities or......
Chip Law Group | Global | 22 Feb 2023
The Rise of Biotech Startups: Advancing Science and Medicine through Innovation
The COVID-19 pandemic has had a major impact on various industries globally, but the biotech industry has proven to be resilient. Initially, the…
Chip Law Group | Global | 21 Feb 2023
バイオテック・スタートアップの台頭。イノベーションで科学と医療を発展させる
COVID-19のパンデミックは、世界のさまざまな産業に大きな影響を与えましたが、バイオテクノロジー産業は回復力があることが証明されました。…
K&S Partners | India | 11 Jan 2023
Medical devices and diagnostic inventions in India: patenting trends
🕑 4 minutes The Indian medical devices market is the fourth largest in Asia and among the top 20 globally. As of 2020, the Indian medical devices market was estimated to be worth $12 billion, with an expected compound annual growth rate of 15%. IP laws – primarily those concerning patents – play a crucial role in promoting innovation relating to medical devices. This article, part of a......
Studio Legale Previti | Italy | 15 Dec 2022
L'obbligo della DPIA e della consultazione preventiva nella ricerca medica alla luce del Codice Privacy e del Parere del Garante Privacy del 30/06/2022
Affinché il trattamento di dati personali per scopi di ricerca scientifica sia svolto lecitamente non è sufficiente il rispetto delle specifiche…
Slaughter and May | United Kingdom | 14 Dec 2022
How might the R&D tax relief regime review affect investment in the life sciences sector?
🕑 8 minutes In 2020, the life sciences sector had an annual turnover of £89 billion. As UK investment in the life sciences sector continues to grow, a natural consequence is that the research and development (R&D) tax regime will play a key role in incentivising investment by reducing the costs of innovation. This article focuses on some of the recent developments coming out of the UK......
Mintz | Global, USA | 10 Jun 2022
Seizing Opportunity: The Post-Pandemic Future of Life Sciences M&A 2022
Life sciences M&A reached peak levels and a near-record total deal value in 2021, fueled by a boom in private equity investments and industry…
Previous page 1 Next page
